Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Aberforth Smaller Companies Trust PLC ( (GB:ASL) ) has provided an update.
Aberforth Smaller Companies Trust plc has repurchased 14,000 of its own ordinary shares on 26 January 2026 at a price of 1,663.05p per share under the authority granted at its March 2025 AGM. Following this latest buyback and cancellation, the trust has 79,444,105 ordinary shares in issue, with a total of 3,215,000 shares bought back under the current mandate, a move that typically signals capital management aimed at enhancing net asset value per share and potentially supporting the share price for existing investors.
The most recent analyst rating on (GB:ASL) stock is a Buy with a £1850.00 price target. To see the full list of analyst forecasts on Aberforth Smaller Companies Trust PLC stock, see the GB:ASL Stock Forecast page.
Spark’s Take on GB:ASL Stock
According to Spark, TipRanks’ AI Analyst, GB:ASL is a Outperform.
The score is driven mainly by solid financial strength (conservative leverage and generally strong profitability/cash flow) tempered by high earnings volatility. Technicals are supportive with an established uptrend, while valuation is reasonable but not especially cheap. Ongoing share buybacks add a modest positive tailwind.
To see Spark’s full report on GB:ASL stock, click here.
More about Aberforth Smaller Companies Trust PLC
Aberforth Smaller Companies Trust plc is a UK-listed investment trust focused on smaller companies, providing investors with exposure to a diversified portfolio of UK smaller-cap equities. The trust is managed by Aberforth Partners LLP and aims to deliver long-term returns by investing in undervalued businesses within the UK smaller companies segment.
Average Trading Volume: 142,836
Technical Sentiment Signal: Buy
For detailed information about ASL stock, go to TipRanks’ Stock Analysis page.

